<DOC>
	<DOCNO>NCT01943383</DOCNO>
	<brief_summary>Patients enrol study complete one parent study `` Pharmacogenomic Evaluation Antihypertensive Responses '' ( PEAR-1 PEAR-2 ) evaluate well blood pressure control medication . Patients current study provide single tube blood use create adult stem cell convert cell type , like heart vasculature . Patients ask return follow visit .</brief_summary>
	<brief_title>Pharmacogenomic Evaluation Antihypertensive Responses Induced Pluripotent Stem ( iPS ) Cells Study</brief_title>
	<detailed_description>If patient decide participate study , 1 visit study include blood draw . Upon arrival clinic , study explain patient detail . The patient ask time sign consent form . The patient opportunity ask question research staff answer question . If patient decides participate study sign consent form , blood sample collect vein arm . A total 2 teaspoon full blood drawn study . During visit , addition collect blood sample , patient ask medical history medication currently take , vital sign assess , include blood pressure , pulse , temperature . Blood drawn train nurse phlebotomist family medicine clinic Gainesville , Florida . The blood sample process laboratory University Florida , establishment iPS cell . iPS cell retain patient 's genetic makeup make useful research . Several experiment conduct cell provide data use learn genetic marker lead difference blood pressure response medicine . These cell use 8 year .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>participation parent trial PEAR ( 2012005 ) PEAR2 ( 2712010 ) assign diuretic arm participation parent trial PEAR ( 2012005 ) PEAR2 ( 2712010 ) assign beta blocker arm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hypertension</keyword>
</DOC>